JPMorgan is overweight on Reliance with a target of Rs 1200. Shale gas, petchem and India-centric service sector investments provide growth visibility and value options. They feel regulatory concerns are overdone.
JPMorgan is overweight on Glenmark as well with a target of Rs 400. The company's core business is benefiting from rising healthcare spends in emerging markets and cost reduction measures in developed markets, driving adoption of generics as innovator drugs go off-patent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.